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Abstract
-Catenin is an essential component of the canonical Wnt signaling system that controls decisive steps in development. We employed
here two conditional -catenin mutant alleles to alter -catenin signaling in the central nervous system of mice: one allele to ablate -catenin
and the second allele to express a constitutively active -catenin. The tissue mass of the spinal cord and brain is reduced after ablation of
-catenin, and the neuronal precursor population is not maintained. In contrast, the spinal cord and brain of mice that express activated
-catenin is much enlarged in mass, and the neuronal precursor population is increased in size. -Catenin signals are thus essential for the
maintenance of proliferation of neuronal progenitors, controlling the size of the progenitor pool, and impinging on the decision of neuronal
progenitors to proliferate or to differentiate.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Precursor cells that generate the various differentiated
cell types of the central nervous system are generally lo-
cated in defined areas, which frequently correspond to the
ventricular zones of the developing nervous system. During
much of development, neural precursors proliferate to re-
new the progenitor pool, and in parallel, give rise to post-
mitotic cells that move out of the progenitor areas (Temple,
2001). The balance between the generation of precursor and
postmitotic cells shifts during development, but has to be
tightly controlled to guarantee the formation of the appro-
priate neuronal cell numbers and the size of the tissue
domains.
-Catenin is a central and essential component of the
canonical Wnt signaling pathway and acts downstream of
the Frz and LRP receptors (Huelsken and Birchmeier, 2001;
Moon et al., 2002; Wodarz and Nusse, 1998). In the pres-
ence of Wnt signals, -catenin is stabilized and translocates
to the nucleus, where it interacts with transcription factors
of the LEF/TCF family to induce changes in gene expres-
sion (Behrens et al., 1996; Willert et al., 2002). In the
absence of Wnt signals, the N-terminus of -catenin is
phosphorylated by casein kinase I on serine residue 45;
GSK3 then phosphorylates the serine/threonine residues at
positions 41, 37, and 33 (Amit et al., 2002; Liu et al., 2002;
Schwarz-Romond et al., 2002). Fully phosphorylated
-catenin is subsequently ubiquitinated and degraded by
proteosomes (Aberle et al., 1997). Mutations that affect
these N-terminal phosphorylation sites have been observed
in various tumors and lead to a stabilization of -catenin
and enhanced signaling activity (Bienz and Clevers, 2000;
Moon et al., 2002; Polakis, 2000). N-terminal sequences
containing these phosphorylation sites are encoded by exon
3 of the -catenin gene. Using Cre/loxP technology, exon 3
was removed in the mouse intestine, resulting in the expres-
sion of activated -catenin and the formation of tumors
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(Harada et al., 1999). However, only canonical Wnt signals
are transmitted by the -catenin-dependent pathway. Other,
noncanonical Wnt signals are mediated by Jun N-terminal
kinase (planar cell polarity pathway) or by Ca2 (Boutros et
al., 2000; Kuhl et al., 2000; Niehrs, 2001; Tada et al., 2002).
During development, Wnts and their receptors are ex-
pressed in complex spatiotemporal patterns throughout the
nervous system, which are often overlapping (Parr et al.,
1993). Genetic analysis in mice has indicated that signals
provided by these factors can control growth and/or pattern-
ing in the central nervous system (Brault et al., 2001; Dick-
inson et al., 1994; Galceran et al., 2000; Ikeya et al., 1997;
Lee et al., 2000; McMahon and Bradley, 1990; McMahon et
al., 1992; Muroyama et al., 2002; Pinson et al., 2000;
Thomas and Capecchi, 1990). For instance, mutation of
Wnt1 in mice leads to a loss of cells at the midhindbrain
boundary (McMahon et al., 1992). Similarly, conditional
mutation of -catenin in the Wnt1 expression domain by the
use of the cre-loxP system leads to an elimination of the
cells at the midhindbrain boundary (Brault et al., 2001). In
contrast, overexpression of Wnt1 or ectopic expression of
activated -catenin in the developing chick spinal cord or
mouse forebrain, respectively, results in an enlarged mass of
the neural tissue (Dickinson et al., 1994; Chenn and Walsh,
2002). However, the complexity of the expression patterns
of Wnts and their receptors has precluded an assessment of
a general function of Wnt signals in development of the
nervous system. -Catenin represents a central and nonre-
dundant signaling component in the canonical Wnt path-
way, and its activation or ablation allows therefore a general
assessment of canonical Wnt signals. We used here two
conditional mutant -catenin alleles in mice: one allele to
express a constitutively active -catenin and the second
allele to ablate -catenin in the central nervous system
(Harada et al., 1999; Huelsken et al., 2001). In mice that
express a stabilized -catenin, the central nervous system is
much enlarged, whereas after ablation of -catenin, the
tissue mass is reduced. We demonstrate that -catenin sig-
nals control proliferation of progenitors, and that they im-
pinge on the decision of neuronal progenitors to proliferate
or differentiate. In the presence of -catenin signals, pro-
genitors exit the cell cycle less frequently, and instead,
continue to proliferate. It is noteworthy that these changes
are observed in various regions of the nervous system,
indicating that -catenin signals can, in general, control the
size of the precursor pool.
Materials and methods
Mouse strains and X-gal staining
Mouse strains harboring the floxed alleles of -catenin
(-catloxEx3–6; -catloxEx3) as well as the transgenic mouse
line that expresses cre-recombinase under the control of the
Brn4 promoter (bcre-32 line) have been described (Ahn et
al., 2001; Harada et al., 1999; Huelsken et al., 2001). Geno-
typing was performed by PCR on DNA prepared from the
yolk sac. To verify the expression pattern of cre-recombi-
nase, a lacZ reporter line was used (Akagi et al., 1997) and
stained with X-gal. Mice with a conditional loss- (Brn4cre;
-catfloxEx3–6/floxEx3–6) or gain- (Brn4cre; -cat/floxEx3) of-
function mutation in the nervous system were generated by
crossings. To detect -catenin protein in the tissue of these
mutant mice, spinal cords from mouse embryos at day 11.5
of embryonic development were dissected, and the tissue
was homogenized. Whole cell lysate was subjected to SDS–
PAGE and Western blotting using anti--catenin or anti-
p120 antibody (Transduction Laboratories, Lexington, KY,
USA).
Histology and immunohistology
Embryos were dissected, staged according to somite
number, and fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS) overnight. For frozen sections, fixed
embryos were rinsed with PBS, soaked in cold 30% sucrose,
and embedded in OCT compound. For paraffin sections,
embryos were dehydrated in ethanol, cleared in toluol, and
embedded in paraffin. Immunohistochemistry was per-
formed on paraffin- or cryo-sections. Antibodies used were
directed against -galactosidase (Abcam, Cambridge, UK),
Fig. 1. Introduction of conditional loss- and gain-of-function mutations into the mouse -catenin locus (a) Schematic representation of the wildtype -catenin
locus and of the alleles used for the introduction of loss- and gain-of-function mutations in the nervous system. Coding exons are represented by numbered
boxes and noncoding exons by black bars. The loxP sequences are represented as red arrowheads; exons removed after cre-mediated recombination are
highlighted in red. Tissue-specific recombination in the -catloxEx3–6 locus results in deletion of exons 3–6, and no protein is produced from this recombined
allele (-cat/; cf. Huelsken et al., 2001). Tissue-specific recombination of the -catloxEx3 locus results in the deletion of exon 3 (-catEx3 allele); from
this allele, a shortened form of -catenin is produced that provides Wnt-independent signals and corresponds thus to a gain-of-function mutation (Harada et
al., 1999). Black boxes labeled A and B represent probes used for Southern analysis of recombined -catloxEx3–6 and -catloxEx3 alleles, respectively, and
X and Xb correspond to Xho1 and Xba1 restriction sites. (b) Brn4cre-mediated recombination of a lacZ reporter gene was visualized by X-gal staining in
an E10 embryo; note the pronounced staining in most of the central nervous system. (c) Immunohistochemistry using anti--galactosidase antibodies on an
E10 embryo that carries Brn4cre and the lacZ reporter gene; the section shows the presence of -galactosidase in the entire the spinal cord. (d) Southern blot
of spinal cord DNA of control and mutant embryos. XhoI-digested DNA of -catloxEx3–6/loxEx3–6 (lane 1) and Brn4cre -catloxEx3–6/loxEx3–6 (lane 2) embryos
were hybridized by using probe A; XbaI-digested DNA of -catEx3/ (lane 3) and Brn4cre -catEx3/ (lane 4) embryos were hybridized by using probe
B. (e, f) Western blot analysis of spinal cord extracts of control and conditional mutant E11.5 embryos using anti--catenin (d) and anti-p120 (e) antibodies.
Shown are spinal cords extracts from control (lane 1), conditional loss-of-function (lane 2), and conditional gain-of-function (lane 3) mutant embryos; note
the reduction in the amount of -catenin in the conditional loss-of-function mutants, and the appearance of a shortened -catenin variant in the conditional
gain-of-function mutant mice. Similar amounts of p120 protein were present in the extracts from control and mutant mice. Bars: b, 1 mm; c, 50 m.
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Fig. 2. Changes in the mass of neural tissue in mice with loss- and gain-of-function mutations of -catenin. (a–c) Sections of the spinal cords at the forelimb
level of control (a), loss- (b), and gain- (c) of-function mutant embryos at E12. (d–f) Coronal sections of the midbrain of control (d), loss- (e), and gain- (f)
of-function mutant embryos at E11.5. Sections are stained with toluidine blue. Bars, 100 m.
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-catenin (Hulsken et al., 1994), nestin (Johe et al., 1996),
NeuN (Chemicon, Temecula, CA, USA), and neuron-spe-
cific class III -tubulin (TuJ1 antibody) (BAbCO, Rich-
mond, CA, USA); secondary antibodies used were goat
anti-mouse or goat anti-rabbit IgG conjugated with Cy3
(Sigma, Mu¨nchen, Germany) or Alexa Fluor 488 (Molecu-
lar Probes, Eugene, OR, USA). For TUNEL staining, an “in
situ cell death kit-fluorescein” was used (Roche Pharma,
Mannheim, Germany). To prepare semithin sections, tissues
were dehydrated and embedded in Technovit 7100 (Kulzer
Histo-Technik, Wehrheim, Germany), and the sections were
stained with toluidine blue O.
BrdU (200 g/g body weight) was injected intraperito-
neally into pregnant mice. At various time points after
injection, tissues were dissected and fixed overnight in 4%
paraformaldehyde in PBS. To detect BrdU neurons or
progenitor cells on paraffin sections, the cells were first
labeled with TuJ1 or anti-NeuN and the appropriate second-
ary antibodies. Sections were then postfixed in 4% PFA,
incubated in 2 N HCl (30 min), and neutralized, and sub-
sequently the BrdU nuclei were visualized by the use of rat
anti-BrdU antibodies (Abcam, Oxford, UK). Nuclei were
stained with 0.5 g/ml LDS751 (Molecular Probes, Eugene,
OR, USA) in PBS. Sections were inspected by a confocal
microscope (LSM 510 META; Zeiss, Go¨ttingen, Germany).
Images were processed by using Adope Photoshop, and
cells and nuclei were counted on such images.
All counts were performed on sections on the forelimb
level of embryos at the indicated stages. The number of
BrdU nuclei in the entire spinal cord was determined. For
the determination of the proliferation and apoptosis rates of
progenitors, the number of progenitor cells were counted;
these correspond to the number of nuclei in the TuJ1
progenitor area. The proliferation rate corresponds to the
number of BrdU nuclei in the entire spinal cord divided by
the number of progenitor nuclei on the same section. The
apoptosis rate corresponds to the number of TUNEL nu-
clei in the TuJ1 progenitor area divided by the number of
progenitor nuclei in the TuJ1 progenitor area on each
section. The percentage of differentiated neurons was de-
fined as the number of NeuN cells divided by the number
of spinal cord cells on each section. To determine the
differentiation rate, BrdU nuclei in the spinal cord were
counted 24 h after administration of BrdU. The differenti-
ation rate corresponds to BrdU/NeuN double-positive cells
divided by the number of BrdU nuclei on each section.
The displayed numbers are the average determined by
counting three to four sections of two to three individual
animals.
Results
To investigate the function of -catenin in the develop-
ing central nervous system, we used two distinct mutant
alleles to introduce loss- and gain-of-function mutations
into the mouse -catenin gene (Fig. 1a). The first allele
contains two loxP sites that surround exons 3–6 (-
catloxEx3–6). Upon recombination, no -catenin protein is
produced, and the recombined allele corresponds thus to a
null-mutation (Huelsken et al., 2001). The second allele
contains two loxP sites that surround exon 3 and a neigh-
boring neomycin-resistance cassette (-catloxEx3); after cre-
induced deletion of exon 3, activated -catenin protein
(-catEx3) is produced, which lacks N-terminal sequences
essential for -catenin degradation (Harada et al., 1999). To
introduce mutations into the developing central nervous
system, a transgenic mouse strain that expresses cre under
the control of the Brn4 promoter was employed (Ahn et al.,
2001). Cre activity in Brn4cre transgenes was assessed with
the help of a lacZ indicator strain (Fig. 1b and c, and data
not shown). In mouse embryos that carry Brn4cre and a
cre-inducible lacZ reporter, cre activity was first detected at
E8.5 in the future di- and mesencephalon, and subsequently
expanded into other areas of the nervous system. Further
caudally, lacZ expression was observed first in the hindbrain
and subsequently expanded into the spinal cord. In the
spinal cord, LacZ expression initiated in a ventral domain
and had spread dorsally by E10. Analysis of -galactosidase
by immunohistology demonstrates that, at E10, the majority
of cells in the entire spinal cord had undergone recombina-
tion and expressed -galactosidase in such indicator mice
(Fig. 1c). LacZ expression was, however, not detected in
neural crest cells and neural crest cell derivatives. Further
rostrally, expression extended from the di- and mesenceph-
alon first into the optic stalk and then into the forebrain. In
the forebrain, expression was restricted to few cells at E10,
but was widespread at subsequent stages.
The Brn4-cre strain was then used to introduce mutations
into the -catenin alleles, and the extent of recombination of
the -catenin loci was tested by Southern hybridization
(Fig. 1d). At E11.5, only a minor proportion of the -catflox
DNA had not recombined in the spinal cord of mice with a
-catloxEx3–6/loxEx3–6 genotype by E11.5. Similarly, a large
proportion of the -catloxEx3-allele had recombined in mice
with a -catloxEx3/ genotype by E11.5. The effect of the
recombination on -catenin protein was assessed by immu-
nohistology and Western blot analysis (Fig. 1e and f, and
data not shown). In mice with cre-induced loss-of-function
mutation, -catenin staining intensity in the E10.5 spinal
cord was reduced when analyzed by immunohistochemis-
try, and little -catenin protein was detected by immuno-
blotting at E11.5 (lane 2 in Fig. 1e). In mice with cre-
induced gain-of-function mutation in the -catenin locus,
the expected shorter variant of -catenin (-catEx3) was
detected (lane 3 in Fig. 1e).
In mice that carry loss- or gain-of-function mutations in
-catenin, major changes in the size and histology of the
spinal cord and brain were detected (Fig. 2). The spinal cord
of embryos with ablated -catenin was significantly smaller
than that of control embryos, and a well-defined ventricular
zone or ventricle was absent at E12 (Fig. 2b; compare with
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control in a). At earlier stages, a reduced size of the spinal
cord and its ventricular zone were apparent (see Fig. 6b and
e, and data not shown). In contrast, the spinal cord and its
ventricular zone of the embryos that express the activated
-catenin was enlarged at E10.5 and subsequent stages and
appeared undulated at E12 (Fig. 2c). Similar changes were
also observed in the brain; for instance, the tissue mass of
the midbrain was decreased or enlarged in loss- or gain-of-
function mutants, respectively (Fig. 2d–f).
Precursor cells and differentiated neurons were visual-
ized by immunohistochemistry, using anti-nestin (shown in
green) and TuJ1 (shown in red) antibodies (Fig. 3). Com-
pared with control mice, the area occupied by progenitors
was reduced in size in the spinal cord of loss-of-function
mutants (Fig. 3b; compare with a). By E11.5, a clearly
defined progenitor area was not apparent ventrally; a dorsal
progenitor domain was still discernable at this stage (Fig.
3b), but absent by E12 (see Fig. 7b). Instead, a proportion-
ally larger area of the spinal cord was occupied by differ-
entiated neurons. Similarly, progenitor domains in the mid-
brain and other brain areas were strongly reduced in size in
the loss-of-function mutants at E11.5 (Fig. 3d and e, and
data not shown). In contrast, in mice with a gain-of-function
-catenin mutation, the progenitor zone of the spinal cord
was enlarged, and a relatively small proportion of the spinal
cord area was occupied by differentiated neurons (Fig. 3c).
Progenitor domains in the midbrain and other brain areas
were also increased in size (Fig. 3d and f, and data not
shown). Nrarp, Hes5, and Hes1 are expressed in neuronal
progenitors and are genes whose expression is controlled by
Notch signaling (Campos-Ortega, 1995; Kageyama and
Ohtsuka, 1999; Krebs et al., 2001; Lamar et al., 2001).
These genes are expressed at similar intensities in progen-
itor cells in the spinal cord of control and conditional mutant
mice at E11.5 (Fig. 4, and data not shown). However, the
spinal cord area occupied by cells that express Hes1, Hes5,
or Nrarp was smaller in the loss-of-function mutants (Fig.
4b and e, and data not shown). In gain-of-function mutants,
the area occupied by Hes1-, Hes5-, or Nrarp-expressing
cells was enlarged (Fig. 4c and f, and data not shown). We
conclude that loss of -catenin function is associated with a
decrease of the progenitor pool in the nervous system of
mouse embryos. In contrast, gain-of-function mutations in
-catenin result in an increase in the progenitor pool.
Conductin (axin II) is a gene whose expression is in-
duced by canonical Wnt signals in colon carcinoma cells
(Lustig et al., 2002). In the spinal cord of control mice at
E9.5, conductin is expressed in dorsally located progenitors
and in a stripe of progenitors cell located in the ventral
domain. During subsequent development, only the dorsal
domain is maintained, and at E11.5, the most dorsally lo-
cated progenitors still express conductin (Fig. 5a). Expres-
sion of conductin in the spinal cord is abolished in embryos
with a cre-induced loss-of-function mutation (Fig. 5b). Ex-
pression is not only increased, but also observable in the
entire progenitor domain in embryos with a cre-induced
gain-of-function mutation (Fig. 5c). This is consistent with
a loss- and gain-of-function in the canonical Wnt signaling
pathway by cre-induced recombination of the -catloxEx3–6
and -catloxEx3 alleles.
BrdU injections were used to assess proliferation of cells
in the spinal cord, and BrdU-positive cells (green) and
TuJ1-positive neurons (red) were visualized (Fig. 6a–c).
Compared with controls, the number of cells that had in-
corporated BrdU was reduced in the loss-of-function mu-
tants (Fig. 6a and b). Proliferation of spinal cord cells was
quantified at different stages of development (Fig. 6g). Total
number of BrdU-positive cells in the spinal cord of control
and loss-of-function mutants were similar at E10, but were
reduced by 45 and 50% at E11 or E11.5, respectively.
Proliferation rates (BrdU cells/total number of progeni-
tors) were determined in the spinal cord at E11 (Fig. 6h).
Compared with controls, the proliferation rate in the spinal
cord of loss-of-function mutants was reduced by 35%. The
number of apoptotic cells was assessed by TUNEL staining
(Fig. 6d–f), and the rate of progenitor cell death was deter-
mined (TUNEL progenitor cells/total number of progeni-
tors). Compared with control tissue, the rate of progenitor
cell death in the loss-of-function mutant was increased 4.8-
fold (Fig. 4i). Decreased proliferation and increased apo-
ptosis were also apparent in the brain of loss-of-function
mutants (data not shown). We conclude from these experi-
ments that decreased proliferation as well as increased cell
death account for the reduction in the numbers of progeni-
tors and thus the smaller overall size of the neural tissue in
the loss-of-function mutants.
In contrast, gain-of-function mutants showed increased
proliferation in progenitors of the spinal cord and forebrain,
midbrain, as well as hindbrain (Fig. 6c, and data not shown).
Compared with the spinal cord of control animals, numbers
of BrdU-positive cells in the spinal cord were increased by
110 and 300% at E11 or E11.5, respectively (Fig. 4g).
Proliferation rates in the spinal cord was increased 1.4-fold
at E11 (Fig. 4h), and the rate of progenitor cell death was
increased 6.7-fold (Fig. 4i). Increased apoptosis was also
apparent in the brain of these mutant mice. We conclude
from these data that enhanced proliferation is an important
cause of the net increase in the size of the progenitor pool
and neural tissue mass in the -catenin gain-of-function
mutants.
We next assessed to what extent changes in the differ-
entiation capacities of progenitors contribute to the pheno-
type observed in the loss- or gain-of-function mutants (Fig.
7). The proportion of differentiated neurons in the spinal
cord (number of NeuN cells/total cell number in the spinal
cord) was determined at E12 (Fig. 7d). In the spinal cord of
loss-of-function mutants, proportionally more neurons
(NeuN cells) were present (Fig. 7b and d). This indicated
that not only the growth of progenitors, but also their dif-
ferentiation capacity might be affected by the mutation. To
investigate this further, pulse chase experiments were per-
formed by injection of BrdU at E11 and analysis of BrdU-
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Fig. 3. Changes in size of the neural progenitor pool in -catenin mutant mice. Neural progenitors and differentiated neurons were visualized by
immunohistology, using antibodies directed against the neuron-specific TuJ1 (red) and the progenitor-specific nestin (green) antigens. (a–c) Sections of the
spinal cords at the forelimb level of control (a), loss-, (b) and gain- (c) of-function mutant embryos at E11.5. (d–f) Coronal sections of the midbrain of control
(d), loss- (e), and gain- (f) of-function mutant embryos at E11.5. Bars, 100 m.
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Fig. 4. Expression of Nrarp and Hes5 in -catenin mutant mice. Expression of Nrarp (a–c) and Hes5 (d–f) was analyzed by in situ hybridizations. Sections
of the spinal cord at the forelimb level of control (a, d), loss- (b, e), and gain- (c, f) of-function mutant embryos at E11.5. Bar, 100 m.
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Fig. 5. Expression of conductin in -catenin mutant mice. (a–c) Expression of conductin was analyzed by in situ hybridisation. Sections of the spinal cord
at the forelimb level of control (a), loss- (b), and gain- (c) of-function mutant embryos at E11.5. Bar, 100 m.
Fig. 6. Changes in proliferation of neural progenitors in -catenin mutant mice. (a–c) Proliferation of neural progenitors in the spinal cord was assessed by
BrdU injection in control (a), loss- (b), and gain- (c) of-function mutant embryos at E11. BrdU-positive nuclei were visualized 2 h after injection by using
anti-BrdU antibodies (green), and differentiated neurons using TuJ1 antibodies (red). (d–f) Apoptosis in the spinal cord was assessed by TUNEL assay of
control (d), loss- (e), and gain- (f) of-function mutant embryos at E11. TUNEL-positive nuclei are depicted in green, nuclei are depicted in blue, and
differentiated neurons were visualized by using TuJ1 antibodies (red). (g) Number of BrdU-positive nuclei in the spinal cords of E10, E11, and E11.5 embryos
observed 2 h after BrdU injection. Values for control, loss-, or gain-of-function mutations are depicted by white, hatched, and black bars, respectively. (h)
Proliferation rates in the spinal cord of E11 embryos with the indicated genotypes. The proliferation rate was defined as the number of BrdU nuclei in the
spinal cord/total number of nuclei in the progenitor zone of the spinal cord observed 2 h after BrdU injection. The average proliferation rate in control embryos
was taken as 1. (i) Rate of apoptosis in the spinal cord of E11 embryos with the indicated genotypes. The rate of apoptosis was defined as the number of
TUNEL-positive cells in the progenitor zone/total number of nuclei in the progenitor zone; the average apoptosis rate of progenitor cells in control mice was
taken as 1. The displayed numbers are the average determined by counting three to four sections of two to three individual animals. Error bars represent
standard deviation. Bar, 100 m.
Fig. 7. Changes in the differentiation rate of neuronal progenitors in -catenin mutant mice. (a–c) BrdU incorporation into neural progenitors and neurons
24 h after BrdU injection at E11 in control (a), loss- (b), and gain- (c) of-function mutant embryos, as assessed by immunohistochemistry using anti-BrdU
(green) and anti-NeuN (red) antibodies. (d) Percentage of differentiated NeuN neurons in the spinal cord of control (white bar), loss- (hatched bar), and
gain-of-function (black bar) mutant embryos at E12, compared with the total cell number in the spinal cord. (e) Number of BrdU/NeuN double-positive cells
per section in the spinal cord of control, loss-, and gain-of-function mutant mice observed 24 hrs after BrdU injection. The average number of BrdU/NeuN
double-positive cells neurons in control embryos was taken as 1. (f) Differentiation rates of neural progenitors in the spinal cord of control, loss-, and
gain-of-function mutant embryos. The differentiation rate was defined as the number of BrdU/NeuN double-positive neurons in the spinal cord/total number
of BrdU cells in the spinal cord observed 24 h after BrdU injection. The average differentiation rate in control embryos was taken as 1. The displayed
numbers are the average determined by counting three to four sections of two to three individual animals. Error bars represent standard deviation. Bar,
100 m.
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positive neurons at E12. Whereas the absolute number
BrdU/NeuN double-positive cells was similar to that ob-
served in control mice, the ratio of proliferating cells that
had differentiated into neurons (i.e., the number of BrdU/
NeuN double-positive cells/number of BrdU-positive cells)
was increased (Fig. 7e and f). Thus, the probability that
progenitors differentiate into neurons is higher in the spinal
cord of loss-of-function mutants than in control mice.
Differentiation capacity of spinal cord progenitors was
also analyzed in gain-of-function mutants. The proportion
of neurons among spinal cord cells was smaller in gain-of-
function mutants than in control mice (Fig. 7c and d). Pulse
chase experiments demonstrated that the ratio of proliferat-
ing cells that had differentiated into neurons (i.e., the num-
ber of BrdU/NeuN double-positive cells/number of BrdU-
positive cells) was decreased (Fig. 7c and f). However,
many neuronal BrdU cells were detected in the gain-of-
function mutant mice, indicating that neuronal differentia-
tion was impaired but not blocked (Fig. 7c and e). Thus, the
probability that progenitors differentiate is lower in the
presence of activated -catenin, which contributes to the net
increase in the size of the progenitor pool.
Discussion
We report here the ablation of -catenin and the expres-
sion of an activated -catenin in the nervous system, using
conditional mutagenesis in mice. Ablation of -catenin re-
sults in a marked decrease of the overall size of the nervous
system. In contrast, the expression of an activated -catenin
causes a large size increase. The underlying cause for these
phenotypes is changes in the proliferation rate of neural
progenitors, accompanied by a shift in the balance between
self renewal and differentiation. This indicates that canon-
ical Wnt signals, which are mediated by -catenin and its
downstream interaction partners, control proliferation and
the balance between progenitor expansion and differentia-
tion. We observe these changes in many areas in the devel-
oping nervous system, i.e., throughout the entire spinal cord
as well as in the brain. Gene ablation studies have previ-
ously implicated TCF4, a transcription factor and down-
stream interaction partner of -catenin, in the maintenance
of a distinct stem cell compartment, the self-renewing pro-
genitor cells in the intestinal crypts (van de Wetering,
2002). The genetic program controlled by -catenin/TCFs
appears thus to control the maintenance of distinct stem cell
types, neural and intestinal stem cells.
The balance between proliferation and differentiation of
progenitor cells in the nervous system
Notch signaling has been implicated in regulating the
balance between neuronal differentiation and progenitor
pool expansion in the mammalian central nervous system
(Gridely, 1997; Kageyama and Ohtsuka, 1999). Notch ac-
tivity suppresses neuronal differentiation and keeps cells in
the progenitor pool. Ablation of Notch or of the main
effectors of Notch signals, Hes1 and Hes5, causes preco-
cious neuronal differentiation (de la Pompa et al., 1997;
Lutolf et al., 2002; Nakamura et al., 2000; Ohtsuka et al.,
1999). However, remaining progenitors in these mutants do
not appear to change their proliferation rate, indicating that
Notch signaling affects primarily the decision of progenitor
cells to differentiate (Lutolf et al., 2002; Nakamura et al.,
2000). This is in contrast to the changes we observed in the
nervous system of -catenin mutant mice, where prolifera-
tion of progenitors is affected in a profound manner and
soon after the mutations are induced by the cre-recombi-
nase. Not only the differentiation rate, but also the decision
between self-renewal and differentiation is changed in the
neural tissue of the gain-of-function mutant mice. Notch
signaling, as assessed by the induction of the Notch respon-
sive genes Hes5 or Nrarp, can occur in these mutant mice.
-Catenin appears thus to affect the decision of cells to self
renew or to differentiate in a Notch-independent manner.
However, subtle effects on Notch signaling cannot be ex-
cluded at this point. The major changes in proliferation that
are observed in these mutants show that -catenin and
Notch signals elicit principally distinct responses in neural
stem cells, and they establish -catenin as potent regulator
of proliferation. In addition, apoptosis rates are increased in
the nervous system of the gain- and loss-of-function mutant
mice, which might appear unexpected and even contradic-
tory. It should, however, be noted that both types of exper-
imental manipulations, which increase or decrease transmis-
sion of canonical Wnt signals, induce apoptosis also in other
tissues (Hasegawa et al., 2002; Hsu et al., 2001; Ioannidis et
al., 2001; Wong et al., 1998). Apoptosis rates in our mutants
might be affected by p53 and c-Myc. Accumulation of p53
can be regulated by -catenin levels, and c-Myc is a known
-catenin target gene. Changes in p53 and c-Myc expres-
sion can impinge on apoptosis rates (Damalas et al., 1999;
Hsu et al., 2001).
-Catenin and Wnt signals in the developing nervous
system
-Catenin is an essential component of canonical Wnt
signaling, and Wnts are known to be expressed in complex
patterns in the nervous system (Parr et al., 1993). Functions
of Wnts in the control of tissue size in the nervous system
have been described, for instance, in the midbrain or the
spinal cord. Ablation of Wnt1 or the Wnt coreceptor LRP6
results in a loss of midbrain and hindbrain tissues (McMa-
hon et al., 1992; Pinson et al., 2000). In Wnt1/Wnt3a com-
pound mutant mice, the dorsal neural tube is reduced in size,
and distinct neural crest derivatives are hypoplastic or com-
pletely absent (Ikeya et al., 1997). Similar changes in de-
velopment of neural crest derivatives were observed in
mutant mice, in which -catenin was ablated in the dorsal
neural tube (Brault et al., 2001). Moreover, mutations in
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LEF1 or Wnt3a result in a marked hypoplasia of the hip-
pocampus (Galceran et al., 2000; Lee et al., 2000). Further
experiments in mouse and chick, in which Wnt1 was over-
expressed in the spinal cord, resulted in an enlargement of
these tissues (Dickinson et al., 1994; Megason and McMa-
hon, 2002). In addition, it was recently reported that over-
expression of constitutively active -catenin in the forebrain
increases the cortex size by enhancing progenitor growth
and inhibiting neuronal differentiation (Chenn and Walsh,
2002). Our study extends this finding to other regions of the
nervous system and provides the analysis of the loss-of-
function of -catenin. In addition to these observations that
relate to a role of Wnt signaling in progenitor growth,
further phenotypes were attributed to defects in patterning
and/or specification of particular domains of the nervous
system. For instance, Wnt1 mutants miss midbrain tissue
and engrailed 1 expression, and engrailed 1 expression is
affected prior to a loss of midbrain tissue (McMahon et al.,
1992). In addition, changes in patterning in the spinal cord
and the hippocampal field, respectively, were observed in
compound Wnt1/Wnt3a and in Lef1 mutant mice (Lee et al.,
2000; Muroyama et al., 2002). Despite this prominent role
of -catenin signals in expansion of the progenitor pool,
additional more subtle local changes can be detected in the
nervous system of our mutant animals. For instance, abla-
tion of -catenin also has an effect on the size of the choroid
plexus that, despite the general brain hypoplasia, is very
much enlarged and appears to arise prematurely at the level
of the lateral ventricles. This may indicate that -catenin
signals not only control growth, but affect also specification
of particular cell types and/or patterning. More work is
required to assess possible changes in patterning and cell
type specification of the central nervous system in these
mutant embryos.
Neuronal stem cells and -catenin/Wnt signals
Prior to neuronal differentiation, the nervous system is
already regionalized, and the developing spinal cord and
brain contains many types of progenitors with distinct de-
velopmental potentials (Jessell, 2000; Simeone, 2002).
However, our -catenin mutations affect the size of the
progenitor pools and tissues in many areas of the spinal cord
and brain. -Catenin and the Wnt pathway can therefore be
considered a fundamental regulator of proliferation of neu-
ral progenitors. Cell cultures of neuronal progenitors rely
typically on the usage of EGF, FGF, or IGF-1 to expand the
multipotent cell population (Cameron et al., 1998). Our
finding of a prominent and general role of -catenin/canon-
ical Wnt signal in the expansion of neural progenitors in
vivo indicates that Wnts, despite their difficult biochemical
properties, might be of use in such in vitro experiments.
Progenitor cells in the developing nervous system express
similar sets of genes as the stem cells that are found in the
adult brain; for instance, nestin marks progenitors in the
embryo and stem cells in the adult. Moreover, these two cell
types resemble each other with respect to their in vitro
differentiation potential and their capacity to repopulate the
central nervous system in vivo (Temple, 2001). Whether
adult stem cells in the brain respond also to -catenin or
Wnt signals remains to be determined.
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